Home/ Supplements/ Coq10/ CoQ10 100 mg Mild Orange Chewable

CoQ10 100 mg Mild Orange Chewable

product on market Tablet or Pill EuroMedica Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for CoQ10 100 mg Mild Orange Chewable
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Chewable Tablet(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Total Carbohydrates
0.5 Gram(s) (1% DV)
Total Sugars
Enhanced Absorption Complex
500 mg

Other Ingredients

Xylitol Maltodextrin Orange Flavor Silica Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommendations: 1 chewable tablet daily or as directed by your healthcare practitioner.

Warnings & Precautions

If pregnant or nursing, consult a healthcare practitioner before use.

Contains xylitol, keep away from pets.

Formulation Notes

EuroMedica's CoQ10 has 8x's higher absorption than traditional CoQ10 because it uses gamma cyclodextrin delivery technology. Supports energy production within cells Replenishes CoQ10 depleted by cholesterol-lowering statin drugs Reduces the risk of oxidative stress Supports cellular energy for healthy aging Supports cognitive health

8x higher absorption

Vegan

No sugar, salt, yeast, wheat, gluten, corn, soy, diary products, artificial coloring, artificial flavoring or artificial preservatives.

Additional Information

Compared to standard CoQ10

Metadata

Product Details

UPC / SKU3 67703 60843 9
DSLD Entry Date2022-04-11
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
DSLD ID261452
Data Updated2026-04-11
Research

Research Evidence

202
Research Sources
55
Avg Quality
86
Meta Analysis
62
Systematic Review
28
Rct
17
Clinical Trial
4
Regulatory Source
2
Other
1
Narrative Review
1
Openfda Safety
A Coenzyme Q10 for heart failure
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis
Meta Analysis BMJ open 2021 PubMed DOI
A Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials
Meta Analysis Irish journal of medical science 2022 PubMed DOI
B Cardioprotective interventions for cancer patients receiving anthracyclines
Meta Analysis The Cochrane database of systematic reviews 2008 PubMed DOI
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Meta Analysis Reproductive sciences (Thousand Oaks, Calif.) 2023 PubMed DOI
B Coenzyme Q10 Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials
Meta Analysis International journal of molecular sciences 2020 PubMed DOI
B Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis
Meta Analysis Journal of nutritional science 2025 PubMed DOI
B Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Coq10 →
Compare

Similar Products

View all Coq10 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.